| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | CA2491835A1 Mch1r antagonists |
| 01/14/2004 | EP1380579A1 Novel physiologically active substances |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | CN1134444C Epothilone analog and medicine combination |
| 01/14/2004 | CN1134426C Method for preparing substituted benzodihydropyran derivative |
| 01/13/2004 | US6677372 N-(3-benzofuranyl)urea-derivatives |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677337 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002470A1 Compounds useful for the inhibition of aldh |
| 01/08/2004 | CA2491089A1 Compounds useful for the inhibition of aldh |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/06/2004 | US6673833 As antitumor agent |
| 01/06/2004 | CA2099232C Fluoro taxols |
| 01/02/2004 | EP1375467A1 2-Bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373260A1 Dibenzo c]chromen-6-one derivatives as anti-cancer agents |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373219A1 Thiohydantoins and use thereof for treating diabetes |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1373183A1 Permanent surface modifiers |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 12/31/2003 | WO2004000836A1 Hydroxy pyranone derivative and preparation method thereof |
| 12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | CA2490043A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | CA2487346A1 Cannabinoid receptor agonists |
| 12/25/2003 | US20030236431 2-bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof |
| 12/25/2003 | US20030236299 Promoting biosynthsis of collagen; collagenase inhibitors; topical applying to skins |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/23/2003 | US6667318 LFA-1 antagonist compounds |
| 12/23/2003 | CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 12/18/2003 | WO2003082192A3 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/17/2003 | EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 12/17/2003 | EP1370510A2 Hiv integrase inhibitors |
| 12/17/2003 | EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/17/2003 | EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 12/17/2003 | CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides |
| 12/16/2003 | US6664275 C10 heterosubstituted acetate taxanes |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/16/2003 | CA2157114C Process for the preparation of 9-desoxotaxanes |
| 12/11/2003 | US20030229229 Anticancer agents; kinase inhibitors; antiallergens; autoimmune disease; rheumatic diseases; skin disorders |
| 12/11/2003 | US20030229073 Tricyclic compounds and method of treating herpes virus |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/10/2003 | EP1368454A1 Method for detecting a risk of hypertension and uses thereof |
| 12/10/2003 | EP1368346A1 Substituted benzofuran-2-carboxamides derivatives |
| 12/10/2003 | EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 12/10/2003 | EP0628064B2 Photochromic naphthopyrans |
| 12/09/2003 | US6660866 C10 carbonate substituted taxanes |
| 12/09/2003 | US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 12/09/2003 | US6660736 MAO-B inhibitors |
| 12/09/2003 | US6660731 Pyrazole compounds useful as protein kinase inhibitors |
| 12/04/2003 | WO2003099813A1 Novel physiolgically active substances |
| 12/04/2003 | WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 12/04/2003 | WO2002068397A8 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 12/04/2003 | US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 12/04/2003 | US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 12/04/2003 | US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same |
| 12/04/2003 | US20030225082 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 12/04/2003 | CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 12/03/2003 | EP1366028A1 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 12/03/2003 | CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor |
| 12/02/2003 | US6656959 PDE IV inhibiting pyridine derivatives |
| 12/02/2003 | US6656939 Pyrazole compounds useful as protein kinase inhibitors |
| 11/27/2003 | WO2003074508B1 Compounds and methods of treating cell proliferative diseases |
| 11/27/2003 | WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 11/27/2003 | WO2002066617A8 Method for detecting a risk of hypertension and uses thereof |
| 11/27/2003 | US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 11/27/2003 | US20030220360 Tricyclic condensed heterocyclic compounds containing o, s in the ring, and atleast one hydroxy group, useful as antiasthmatic drugs |
| 11/27/2003 | US20030220359 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists |
| 11/27/2003 | US20030220334 Bryostatins exhibit potent activity against a broad range of human cancer cell lines |
| 11/27/2003 | US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
| 11/27/2003 | US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors |
| 11/26/2003 | EP1364947A1 Preparation of isocoumarin derivatives and intermediates for the synthesis thereof |
| 11/26/2003 | EP1363927A2 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides |
| 11/26/2003 | EP1363897A2 Antagonists of mcp-1 function and methods of use thereof |
| 11/26/2003 | EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 11/26/2003 | EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same |
| 11/25/2003 | US6653490 Process for the preparation of ammonium alkoxides |
| 11/25/2003 | US6653340 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway |
| 11/25/2003 | US6653301 For therapy of cancer, diabetes and Alzheimer's disease |
| 11/25/2003 | US6653300 Pyrazole compounds useful as protein kinase inhibitors |
| 11/20/2003 | WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 11/20/2003 | WO2003095421A1 Amino acid analogues |
| 11/20/2003 | WO2003014105A9 Bicyclic compound, production and use as hiv inhibitors |
| 11/20/2003 | WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin |
| 11/20/2003 | US20030216404 Hydroxamic acid derivatives |
| 11/19/2003 | EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device |
| 11/19/2003 | EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors |
| 11/19/2003 | CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same |
| 11/18/2003 | US6649777 C2 substituted taxanes |
| 11/18/2003 | US6649652 Prodrugs for antimicrobial amidines |